Krka, d. d. (WSE:KRK)

Poland flag Poland · Delayed Price · Currency is PLN
686.00
-10.00 (-1.44%)
Feb 13, 2025, 12:43 PM CET
34.51%
Market Cap 21.04B
Revenue (ttm) 8.14B
Net Income (ttm) 1.54B
Shares Out n/a
EPS (ttm) 49.99
PE Ratio 13.64
Forward PE n/a
Dividend 32.10 (4.71%)
Ex-Dividend Date Jul 23, 2024
Volume 511
Average Volume 85
Open 688.00
Previous Close 696.00
Day's Range 686.00 - 688.00
52-Week Range 506.00 - 714.00
Beta 0.53
RSI 61.83
Earnings Date Jan 30, 2025

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. Its prescription pharmaceuticals include medicines for the treatment of cardiovascular, alimentary tract and metabolism, central nervous system, infections, oncology, and other diseases. The company also provides non-prescription products for oral cavity and pharynx; cough and cold; a... [Read more]

Sector Healthcare
Founded 1954
Employees 10,284
Stock Exchange Warsaw Stock Exchange
Ticker Symbol KRK
Full Company Profile

Financial Performance

In 2023, Krka, d. d.'s revenue was 1.81 billion, an increase of 5.18% compared to the previous year's 1.72 billion. Earnings were 313.95 million, a decrease of -13.58%.

Financial numbers in EUR Financial Statements

News

There is no news available yet.